Clinical Neurology NewsFDA finds no evidence of cardiovascular risk in Parkinson’s drugOctober 27, 2015Movement Disorders
Neurology ReviewsCSF Markers May Differentiate Causes of Parkinsonism and Predict DementiaSeptember 30, 2015Movement DisordersParkinson's Disease
Neurology ReviewsThe Diagnosis and Management of Multiple System AtrophySeptember 29, 2015Rare DiseasesMovement DisordersParkinson's Disease
Neurology ReviewsMSA May Be a Prion DisorderSeptember 29, 2015Rare DiseasesMovement DisordersParkinson's Disease
Clinical Neurology NewsPrion-like transmission of neurodegenerative pathology stirs concernSeptember 17, 2015Alzheimer's & CognitionMovement DisordersNeurosurgery & TraumaRare Diseases
Neurology ReviewsCan Nondopaminergic Drugs Help Patients With Parkinson’s Disease?August 27, 2015Movement DisordersParkinson's Disease
Clinical Neurology NewsCSF markers differentiate Parkinson’s, predict related dementiaAugust 10, 2015Alzheimer's & CognitionMovement Disorders
Neurology ReviewsPimavanserin May Relieve Parkinson’s Disease PsychosisJuly 31, 2015Movement DisordersParkinson's Disease
Clinical Neurology NewsPotential Parkinson’s disease drug target: PPAR gamma pathwaysJuly 25, 2015Movement Disorders
Neurology ReviewsEnvironmental and Behavioral Interventions May Alleviate Nonmotor Symptoms of Parkinson’s DiseaseJune 29, 2015Movement DisordersParkinson's Disease
Neurology ReviewsDoes Low Muscle Strength Predict Parkinson’s Disease?June 29, 2015Movement DisordersParkinson's Disease
Neurology ReviewsEarlier Treatment With Rotigotine May Have Long-Term Benefit for Patients With Parkinson’s DiseaseJune 24, 2015Movement DisordersParkinson's Disease
Neurology ReviewsAlpha-Synuclein Is a Target of New Therapeutic Strategies for Parkinson’s DiseaseJune 24, 2015Movement DisordersParkinson's Disease
